{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:00:20Z","timestamp":1790398820649,"version":"4.1.0"},"reference-count":24,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Clin Pharmacol"],"abstract":"<jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>This study aimed to clarify the pharmacological meaning of intoxication as it applies to cannabis\u2010based medicines; distinguish intoxication from related terms such as psychoactive, psychotropic and euphorigenic; and evaluate how these distinctions inform clinical practice, prescribing frameworks and regulatory classification of THC\u2010 and CBD\u2010containing products.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A narrative review of pharmacological, clinical and regulatory literature was conducted, drawing on cannabinoid receptor pharmacology, pharmacokinetic studies of THC and CBD, ICD\u201011 diagnostic criteria for substance intoxication, WHO scheduling assessments and international regulatory frameworks. Evidence was synthesised to develop a coherent clinical taxonomy and to examine the implications of dose, route of administration, patient\u2010level modifiers and statutory definitions for classifying cannabinoids as intoxicants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>THC is a partial CB1 receptor agonist and a dose\u2010 and route\u2010dependent intoxicant. Oral administration produces substantially higher exposure to the active metabolite 11\u2010hydroxy\u2010THC, increasing intoxication likelihood and severity. Patient\u2010specific factors further modify intoxication risk. CBD acts as a negative allosteric modulator at CB1, does not produce euphoria or functional impairment at clinically relevant doses and does not meet ICD\u201011 criteria for an intoxicant. A taxonomy distinguishing psychoactive, psychotropic, euphorigenic and intoxicant is proposed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>THC and CBD differ fundamentally in receptor pharmacology, clinical effects and intoxication potential. Intoxication should be defined by functional impairment, not by psychoactivity alone. Adoption of precise, pharmacologically grounded terminology is essential for rational prescribing, informed consent, patient safety and coherent regulatory policy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/bcp.70840","type":"journal-article","created":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:33:08Z","timestamp":1790397188000},"source":"Crossref","is-referenced-by-count":0,"title":["Cannabis\u2010based medicines: On the topic of intoxication"],"prefix":"10.1002","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0508-2665","authenticated-orcid":false,"given":"Martin","family":"Woodbridge","sequence":"first","affiliation":[{"name":"Medical Affairs &amp; Regulatory Science Woodbridge Research Ltd  Wellington New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurgen","family":"Fleisch","sequence":"additional","affiliation":[{"name":"Anaesthesiology &amp; Pain Medicine, Department of Anaesthesiology &amp; Pain Therapy Leiden University Medical Center (LUMC)  Leiden the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.13882"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41582\u2010019\u20100284\u2010z"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpsc.2020.07.016"},{"key":"e_1_2_10_5_1","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: D9\u2010tetrahydrocannabinol, cannabidiol and D9\u2010tetrahydrocannabivarin","volume":"153","author":"Pertwee R","year":"2008","journal-title":"Br J Pharmacol"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476\u20105381.2011.01238.x"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l1141"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088\u2010200342040\u201000003"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2009.130641"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpet.2024.100017"},{"key":"e_1_2_10_11_1","volume-title":"The health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research","author":"National Academies of Sciences, Engineering, and Medicine","year":"2017"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2018.01.019"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2025.1156"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2008.213"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.13250"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41386\u2010022\u201001478\u2010z"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0704327"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.2174\/157488611798280924"},{"key":"e_1_2_10_19_1","volume-title":"ICD\u201011: International Classification of Diseases, 11th Revision. Section 6C4: Disorders due to Substance Use and Addictive Behaviours","author":"World Health Organization","year":"2022"},{"key":"e_1_2_10_20_1","unstructured":"United Nations.Convention on Psychotropic Substances 1971Vienna UNODC1971. [Also: UN Commission on Narcotic Drugs Decision 63\/7 2 December 2020. Vienna UNODC; 2020.]https:\/\/www.unodc.org\/unodc\/en\/commissions\/CND\/conventions.html"},{"key":"e_1_2_10_21_1","unstructured":"World Health Organization.Cannabidiol (CBD): Critical Review Report. Expert Committee on Drug Dependence 40th Meeting. Geneva WHO2018.https:\/\/cdn.who.int\/media\/docs\/default-source\/controlled-substances\/whocbdreportmay2018-2.pdf"},{"key":"e_1_2_10_22_1","volume-title":"WHO expert committee on drug dependence: forty\u2010first report","author":"World Health Organization","year":"2019"},{"key":"e_1_2_10_23_1","unstructured":"Cannabis Regulators Association (CANNRA).2025Model Policy for Intoxicating HempWashington DC CANNRA 2025https:\/\/www.cannabisregulations.ai"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.2307\/1220524"},{"key":"e_1_2_10_25_1","unstructured":"United States Congress. \u201cContinuing Appropriations Agriculture Legislative Branch Military Construction and Veterans Affairs and Extensions Act 2026.\u201d P.L. 119\u201337 \u00a7781. Enacted 12 November 2025.Washington DC:Congress.gov;2025. See Amendment of Section 297A of the Agricultural Marketing Act of 1946 (7 U.S.C. 1639o).https:\/\/www.congress.gov\/119\/plaws\/publ37\/PLAW-119publ37.pdf."}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bcp.70840","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/bcp.70840","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bcp.70840","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:33:29Z","timestamp":1790397209000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1002\/bcp.70840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":24,"alternative-id":["10.1002\/bcp.70840"],"URL":"https:\/\/doi.org\/10.1002\/bcp.70840","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"article-number":"bcp.70840"}}